Abstract
Significance: Despite the success of T cell–redirecting immunotherapies for blood cancers, toxic, off-target side effects prevent their safe application to other diseases. Part of the challenge lies in our incomplete understanding of T cell receptor (TCR) triggering. Although we know signaling requires TCR phosphorylation, how extracellular TCR/ligand binding produces intracellular phosphorylation is unclear. Using live-cell imaging, we found that just reducing TCR mobility induces T cell signaling. Since native ligands also restrict TCR mobility, our findings suggest that trapping TCRs in tight cell–cell interaction spaces, where large negative-regulatory phosphatases are depleted, might generally initiate T cell signaling. This implies that parameters beyond TCR–ligand affinity could be exploited to fine-tune the specificity and potency of T cell–redirecting agents.
Funding Information
  • Wellcome (207547/Z/17/Z)
  • Royal Society (RP150066)

This publication has 61 references indexed in Scilit: